Related Experiment Videos
[Cutaneous necrotizing vasculitis caused by immunocomplexes during treatment with levamisole]
Bollettino Dell'Istituto Sieroterapico Milanese
|March 31, 1983
Summary
Levamisole, a drug used for polysclerosis, can cause necrotizing vasculitis. This condition presents as skin lesions with specific immune deposits in blood vessels, confirmed by biopsy and immunofluorescence.
Area of Science:
- Dermatology
- Rheumatology
- Immunology
Background:
- Levamisole is an immunomodulatory drug sometimes used to treat autoimmune conditions like polysclerosis.
- Drug-induced vasculitis is a known but uncommon adverse reaction to certain medications.
Observation:
- A young woman treated with levamisole for polysclerosis developed painful skin lesions.
- The cutaneous lesions were characterized by inflammation and tissue death (necrosis).
Findings:
- Biopsy of the skin lesions confirmed leucocytoclastic vasculitis, indicating small blood vessel inflammation.
- Immunofluorescence microscopy revealed deposition of Immunoglobulin G (IgG), Immunoglobulin M (IgM), and complement component 3 (C3) within the affected vessel walls.
Implications:
- This case highlights a potential adverse effect of levamisole, emphasizing the need for vigilance in patients receiving this medication.
- The findings contribute to understanding drug-induced vasculitis and its immunopathological mechanisms.